{"title":"ALK+/EGFRm NSCLC: Lorlatinib Wows; Toward Sub-Q Amivantamab","authors":"Alissa Poh","doi":"10.1158/2159-8290.cd-nw2024-0035","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":502270,"journal":{"name":"Cancer Discovery","volume":"44 14","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/2159-8290.cd-nw2024-0035","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
